MFDS — authorised 29 August 2017
- Marketing authorisation holder: REMPEX PHARMS INC
- Status: likely_approved
🇰🇷 Vabomere in South Korea
MFDS authorised Vabomere on 29 August 2017
Marketing authorisation
Vabomere in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Vabomere approved in South Korea?
Yes. MFDS authorised it on 29 August 2017.
Who is the marketing authorisation holder for Vabomere in South Korea?
REMPEX PHARMS INC holds the South Korean marketing authorisation.